BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32006569)

  • 1. Cyclin D degradation by E3 ligases in cancer progression and treatment.
    Qie S; Diehl JA
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):159-170. PubMed ID: 32006569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.
    Barbash O; Diehl JA
    Cell Cycle; 2008 Oct; 7(19):2983-6. PubMed ID: 18818515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
    Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
    J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fbxo7 gets proactive with cyclin D/cdk6.
    Laman H
    Cell Cycle; 2006 Feb; 5(3):279-82. PubMed ID: 16410730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
    Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
    J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cullin-associated E3 ligases regulate cyclin D1 protein stability.
    Lu K; Zhang M; Wei G; Xiao G; Tong L; Chen D
    Elife; 2023 Nov; 12():. PubMed ID: 37943017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines.
    Achiwa Y; Hasegawa K; Udagawa Y
    Nutr Cancer; 2013; 65(7):1026-33. PubMed ID: 24083669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF
    Lee A; Rayner SL; De Luca A; Gwee SSL; Morsch M; Sundaramoorthy V; Shahheydari H; Ragagnin A; Shi B; Yang S; Williams KL; Don EK; Walker AK; Zhang KY; Yerbury JJ; Cole NJ; Atkin JD; Blair IP; Molloy MP; Chung RS
    Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer.
    Galper J; Rayner SL; Hogan AL; Fifita JA; Lee A; Chung RS; Blair IP; Yang S
    Int J Biochem Cell Biol; 2017 Aug; 89():216-220. PubMed ID: 28652210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.
    Zou T; Lin Z
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis.
    Rezaeian AH; Inuzuka H; Wei W
    Adv Protein Chem Struct Biol; 2023; 135():179-201. PubMed ID: 37061331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D.
    Chaikovsky AC; Li C; Jeng EE; Loebell S; Lee MC; Murray CW; Cheng R; Demeter J; Swaney DL; Chen SH; Newton BW; Johnson JR; Drainas AP; Shue YT; Seoane JA; Srinivasan P; He A; Yoshida A; Hipkins SQ; McCrea E; Poltorack CD; Krogan NJ; Diehl JA; Kong C; Jackson PK; Curtis C; Petrov DA; Bassik MC; Winslow MM; Sage J
    Nature; 2021 Apr; 592(7856):794-798. PubMed ID: 33854239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
    Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
    J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Lost Ligase: CRL4
    Chaikovsky AC; Sage J; Pagano M; Simoneschi D
    DNA Cell Biol; 2021 Dec; 40(12):1457-1461. PubMed ID: 34495753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.